Review




Structured Review

Promega powerplex msi analysis system v1.2
Powerplex Msi Analysis System V1.2, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/msi+analysis+system+v1%2E2/powerplex+msi+analysis+system+v1+2/us12344900-337-8-13
Average 90 stars, based on 1 article reviews
powerplex msi analysis system v1.2 - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Immunohistochemistry:

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: Comparison of MSI score (Newcastle MSI-Plus Assay) and mismatch repair (MMR) protein expression by immunohistochemistry (IHC) for 13 CRCs that were classified as MSI-H based on instability in 2/5 markers using the MSI Analysis System v1.2 (Promega).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [ , ]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [ ]).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [13,14]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [15]).

Article Title: Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material.
Article Snippet: MSI testing was performed by interrogating microsatellites at the following 5 loci (NR-21; BAT-26; BAT-25; NR-24; MONO-27) using MSI Analysis System v1.2 (Promega, Inc., Madison, WI).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: The reference MSI status was determined by the MSI Analysis System v1.2 (Promega) or, where the MSI Analysis System v1.2 result was uncertain, immunohistochemistry and/or MIP amplicon sequencing.

Article Title: Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Article Snippet: Thirteen of the 14 samples at all three input levels showed MSI status concordant with the Promega MSI Analysis system v1.2 ( ).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: MIP amplicon sequencing or the MSI Analysis System v1.2 (Promega, Madison, WI, USA), without paired normal tissue, provided MSI reference results.

Amplification:

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: Comparison of MSI score (Newcastle MSI-Plus Assay) and mismatch repair (MMR) protein expression by immunohistochemistry (IHC) for 13 CRCs that were classified as MSI-H based on instability in 2/5 markers using the MSI Analysis System v1.2 (Promega).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [ , ]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [ ]).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [13,14]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [15]).

Article Title: Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material.
Article Snippet: MSI testing was performed by interrogating microsatellites at the following 5 loci (NR-21; BAT-26; BAT-25; NR-24; MONO-27) using MSI Analysis System v1.2 (Promega, Inc., Madison, WI).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: The reference MSI status was determined by the MSI Analysis System v1.2 (Promega) or, where the MSI Analysis System v1.2 result was uncertain, immunohistochemistry and/or MIP amplicon sequencing.

Article Title: Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Article Snippet: Thirteen of the 14 samples at all three input levels showed MSI status concordant with the Promega MSI Analysis system v1.2 ( ).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: MIP amplicon sequencing or the MSI Analysis System v1.2 (Promega, Madison, WI, USA), without paired normal tissue, provided MSI reference results.

Sequencing:

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: Comparison of MSI score (Newcastle MSI-Plus Assay) and mismatch repair (MMR) protein expression by immunohistochemistry (IHC) for 13 CRCs that were classified as MSI-H based on instability in 2/5 markers using the MSI Analysis System v1.2 (Promega).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [ , ]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [ ]).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [13,14]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [15]).

Article Title: Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material.
Article Snippet: MSI testing was performed by interrogating microsatellites at the following 5 loci (NR-21; BAT-26; BAT-25; NR-24; MONO-27) using MSI Analysis System v1.2 (Promega, Inc., Madison, WI).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: The reference MSI status was determined by the MSI Analysis System v1.2 (Promega) or, where the MSI Analysis System v1.2 result was uncertain, immunohistochemistry and/or MIP amplicon sequencing.

Article Title: Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Article Snippet: Thirteen of the 14 samples at all three input levels showed MSI status concordant with the Promega MSI Analysis system v1.2 ( ).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: MIP amplicon sequencing or the MSI Analysis System v1.2 (Promega, Madison, WI, USA), without paired normal tissue, provided MSI reference results.

Comparison:

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: Comparison of MSI score (Newcastle MSI-Plus Assay) and mismatch repair (MMR) protein expression by immunohistochemistry (IHC) for 13 CRCs that were classified as MSI-H based on instability in 2/5 markers using the MSI Analysis System v1.2 (Promega).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [ , ]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [ ]).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [13,14]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [15]).

Article Title: Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material.
Article Snippet: MSI testing was performed by interrogating microsatellites at the following 5 loci (NR-21; BAT-26; BAT-25; NR-24; MONO-27) using MSI Analysis System v1.2 (Promega, Inc., Madison, WI).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: The reference MSI status was determined by the MSI Analysis System v1.2 (Promega) or, where the MSI Analysis System v1.2 result was uncertain, immunohistochemistry and/or MIP amplicon sequencing.

Article Title: Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Article Snippet: Thirteen of the 14 samples at all three input levels showed MSI status concordant with the Promega MSI Analysis system v1.2 ( ).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: MIP amplicon sequencing or the MSI Analysis System v1.2 (Promega, Madison, WI, USA), without paired normal tissue, provided MSI reference results.

Expressing:

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: Comparison of MSI score (Newcastle MSI-Plus Assay) and mismatch repair (MMR) protein expression by immunohistochemistry (IHC) for 13 CRCs that were classified as MSI-H based on instability in 2/5 markers using the MSI Analysis System v1.2 (Promega).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [ , ]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [ ]).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [13,14]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [15]).

Article Title: Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material.
Article Snippet: MSI testing was performed by interrogating microsatellites at the following 5 loci (NR-21; BAT-26; BAT-25; NR-24; MONO-27) using MSI Analysis System v1.2 (Promega, Inc., Madison, WI).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: The reference MSI status was determined by the MSI Analysis System v1.2 (Promega) or, where the MSI Analysis System v1.2 result was uncertain, immunohistochemistry and/or MIP amplicon sequencing.

Article Title: Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Article Snippet: Thirteen of the 14 samples at all three input levels showed MSI status concordant with the Promega MSI Analysis system v1.2 ( ).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: MIP amplicon sequencing or the MSI Analysis System v1.2 (Promega, Madison, WI, USA), without paired normal tissue, provided MSI reference results.

MSI Assay:

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: Comparison of MSI score (Newcastle MSI-Plus Assay) and mismatch repair (MMR) protein expression by immunohistochemistry (IHC) for 13 CRCs that were classified as MSI-H based on instability in 2/5 markers using the MSI Analysis System v1.2 (Promega).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [ , ]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [ ]).

Article Title: Detection of Mismatch Repair Deficiency in Endometrial Cancer: Assessment of IHC, Fragment Length Analysis, and Amplicon Sequencing Based MSI Testing.
Article Snippet: The latter most commonly involves fragment length analysis of highly informative PCR-amplified microsatellite markers (FLA-PCR [13,14]) using, for example, the Promega MSI Analysis System V1.2, which involves visual assessment of variation at five mononucleotide repeat markers (Promega MSI, [15]).

Article Title: Cytologic testing for mismatch repair deficiency/microsatellite instability and NTRK gene fusion is not routinely indicated in primary pancreaticobiliary carcinoma cell block material.
Article Snippet: MSI testing was performed by interrogating microsatellites at the following 5 loci (NR-21; BAT-26; BAT-25; NR-24; MONO-27) using MSI Analysis System v1.2 (Promega, Inc., Madison, WI).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: The reference MSI status was determined by the MSI Analysis System v1.2 (Promega) or, where the MSI Analysis System v1.2 result was uncertain, immunohistochemistry and/or MIP amplicon sequencing.

Article Title: Detection of Microsatellite Instability in Colorectal Cancer Tissue and Plasma samples using a new Multiplex Droplet Digital PCR kit
Article Snippet: Thirteen of the 14 samples at all three input levels showed MSI status concordant with the Promega MSI Analysis system v1.2 ( ).

Article Title: A novel colorectal cancer test combining microsatellite instability and BRAF/RAS analysis: Clinical validation and impact on Lynch syndrome screening
Article Snippet: MIP amplicon sequencing or the MSI Analysis System v1.2 (Promega, Madison, WI, USA), without paired normal tissue, provided MSI reference results.



Similar Products

90
Promega powerplex msi analysis system v1.2
Powerplex Msi Analysis System V1.2, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/msi+analysis+system+v1%2E2/powerplex+msi+analysis+system+v1+2/us12344900-337-8-13
Average 90 stars, based on 1 article reviews
powerplex msi analysis system v1.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Promega msi analysis system v1.2
Msi Analysis System V1.2, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/msi+analysis+system+v1%2E2/msi+analysis+system/pmc11640224-57-23-22
Average 90 stars, based on 1 article reviews
msi analysis system v1.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Promega msi pcr analysis system v1.2
Msi Pcr Analysis System V1.2, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/msi+analysis+system+v1%2E2/panel+msi+analysis+system+version+1+2/pm39277692-65-20-19
Average 90 stars, based on 1 article reviews
msi pcr analysis system v1.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Promega pcr msi analysis system v1.2
Pcr Msi Analysis System V1.2, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/msi+analysis+system+v1%2E2/panel+msi+analysis+system+version+1+2/pm39277692-66-7-18
Average 90 stars, based on 1 article reviews
pcr msi analysis system v1.2 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results